Patents Represented by Attorney, Agent or Law Firm Jenkins and Wilson P.A.
  • Patent number: 6373427
    Abstract: The invention relates to a radar distance measuring device. An especially linear frequency-modulated high frequency signal is emitted via an antenna and mixed with an echo signal reflected by a target object whose distance is to be determined. The distance of said target object can then be calculated by analyzing the frequency of the mix result. The aim of the invention is to improve the distance resolution or increase the accuracy of measurement. To this end, a first frequency analysis is first carried out to obtain a rough analysis result. Said rough analysis result is used to control a filtering device which then restricts the mix result in its time range to a segment around the frequency of the target object. A discrete Fourier transformation is then carried out for this segment in order to produce an analysis result with a more refined scanning step than the first frequency analysis.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: April 16, 2002
    Assignee: Mikrowellen-Technologie und Sensoren GmbH
    Inventor: Felix Hohne
  • Patent number: 6370521
    Abstract: An integrated computer system architecture for tracking of job data in a document processing environment including an infrastructure built on processes, hardware, software and interfaces designed to monitor and control mail processing and data collection through a variety of manual and machine processes in real-time. Computers, networks, web-based applications, databases and scanners are used to interface and integrate traditional mail processing equipment with customized software. The invention integrates the entire mail production process to form and establish a complete end-to-end system. A job tracking scheme is detailed illustrating a particular data mining application.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: April 9, 2002
    Assignee: Bell & Howell Mail Messaging Technologies Company
    Inventors: Charles R. Pigos, Jr., Pamela S. Austin, Vernon P. Bennett, Linda S. Williams
  • Patent number: 6367219
    Abstract: The present invention relates to a building cavity assembly and, in particular, a building cavity assembly having a thermal break to prevent the development of cold spots acting as a gathering point for condensation. A building assembly comprising an inner and outer skin defining an insulating cavity, a support bar fixedly located in the cavity for mounting the outer skin thereon and an insulating spacer fixedly located between the support bar and the inner skin to provide a thermal break between the inner and outer skins is described. The support bar and the spacer are connected by means of a metal fixing device which passes through at least a part of the support bar and secures it to the spacer and fixes the spacer to the inner skin. The fixing device includes insulating means to insulate it from the support bar and prevent any metal to metal contact therebetween. Methods of use on roof and wall claddings are also described.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: April 9, 2002
    Assignee: New Market Developments Ltd.
    Inventor: Francis Quinlan
  • Patent number: 6363198
    Abstract: An optical fiber cable distribution shelf is disclosed which comprises a cable management clip system in the rear bay as well as a cable management clip system in the front bay of the shelf. The cable management clip systems each include at least one pair of controlled bend clips and at least one divider clip positioned therebeneath in order to control the bend and to route optical fiber into and out of the cable distribution shelf without imparting any undesirable fiber damage or related attenuated signals due to uncontrolled bending of the fibers. Thus, the improved optical fiber cable distribution shelf provides for installing a higher density of fiber optic connections into an optical fiber cable distribution shelf.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: March 26, 2002
    Assignee: Sumitomo Electric Lightwave Corp.
    Inventors: David J. Braga, David W. Kapella, Aditya K. Tariyal
  • Patent number: 6362226
    Abstract: A method of treating autism in a patient. The method includes administering to the patient an effective amount of a glutamine level reducing agent, a glycine level reducing agent or combinations thereof. Representative glutamine level reducing agents are phenylbutyrate and phenylacetate, and a representative glycine level reducing agent is sodium benzoate. Optionally, an N-methyl-D-aspartate receptor antagonist can also be administered to the patient. A representative N-methyl-D-aspartate receptor antagonist is dextromethorphan.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: March 26, 2002
    Assignee: Vanderbilt University
    Inventors: John A. Phillips, III, Susan G. McGrew
  • Patent number: 6355786
    Abstract: Isolated and purified proteins and nucleic acids including a novel member of the immunoglobulin super-family characterized as having SHP-2 binding activity and cell signaling activity and called protein zero related or PZR, and cDNA encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to PZR, and methods of producing the same, are also disclosed. PZR is characterized as having SHP-2 binding activity and cell signaling activity and thus, therapeutic methods involving these activities are also disclosed.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: March 12, 2002
    Assignee: Vanderbilt University
    Inventor: Zhizhuang Zhao
  • Patent number: 6356697
    Abstract: An optical fiber cable distribution shelf is disclosed which comprises at least one stack of pivotably mounted trays that each have a panel of optical adapters mounted to the front of the tray. Thus, each tray is pivotably mounted in the cable distribution shelf and can be pivoted horizontally from a position parallel to center to a forward perpendicular-to-center position for easy access to the front or rear optical fiber connectors leading to the adapters mounted on the tray.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: March 12, 2002
    Assignee: Sumitomo Electric Lightwave Corp.
    Inventors: David J. Braga, Aditya K. Tarival, J. Raymon Zapatero
  • Patent number: 6352724
    Abstract: A method for the topical treatment of skin affected with acne, rosacea, or a combination thereof. Sodium chloride in a substantially pure form is topically applied to the affected skin by gently gliding the sodium chloride over the affected skin in a manner insufficient to cause abrasion and debridement of the affected skin. A solid block of about 98% to about 100% by weight sodium chloride free of a carrier and/or free of other topical acne-treatment medicaments and/or free of other topical rosacea-treatment medicaments should be used. The applied sodium chloride is left on the skin. Preferably, the affected skin is pre-moistened with water from shaving, bathing, splashing water on the skin, and the like prior to gliding the sodium chloride thereon.
    Type: Grant
    Filed: March 11, 1996
    Date of Patent: March 5, 2002
    Inventors: Lesli A. Taylor, Ralph L. Bass
  • Patent number: 6350475
    Abstract: A method for the topical treatment of skin affected with acne, rosacea, or a combination thereof. Sodium chloride in a substantially pure form is topically applied to the affected skin by gently gliding the sodium chloride over the affected skin in a manner insufficient to cause abrasion and debridement of the affected skin. A solid block of about 98% to about 100% by weight sodium chloride free of a carrier and/or free of other topical acne-treatment medicaments and/or free of other topical rosacea-treatment medicaments should be used. The applied sodium chloride is left on the skin. Preferably, the affected skin is pre-moistened with water from shaving, bathing, splashing water on the skin, and the like prior to gliding the sodium chloride thereon.
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: February 26, 2002
    Inventors: Lesli A. Taylor, Ralph L. Bass
  • Patent number: 6346382
    Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: February 12, 2002
    Assignee: Vanderbilt University
    Inventors: Marshall L. Summar, Brian W. Christman
  • Patent number: 6345203
    Abstract: Magnetic Vector Steering (MVS) and Half-Cycle Amplitude Modulation (HCAM) are novel techniques which enhance the powering and control of multiple arbitrarily oriented implant devices. Together, these techniques enable arbitrarily oriented implants to receive power and command, programming, and control information in an efficient manner that preserves battery life and transmission time while reducing overall implant device bulk. By steering the aggregate magnetic field from a near-orthogonal set of AC-energized coils, selected implants can be powered or communicated with at desired times. Communication with individual implants can also be enhanced through half-cycle amplitude modulation —a technique that allows bit rates up to twice the energizing frequency. Unlike prior art systems, power and data transfer can be realized over the same frequency channel.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: February 5, 2002
    Assignee: North Carolina State University
    Inventors: Jeffrey S. Mueller, H. Troy Nagle, Ronald S. Gyurcsik, Arthur W. Kelley
  • Patent number: 6342483
    Abstract: The present invention provides a method of detecting and diagnosing pre-invasive breast cancer by identifying differentially expressed genes in early, pre-invasive breast cancer tissue. Differentially expressed genes can be used as genetic markers to indicate the presence of pre-invasive cancerous tissues. Microscopically-directed tissue sampling techniques combined with differential display or differential screening of cDNA libraries are used to determine differential expression of genes in the early stages of breast cancer. Differential expression of genes in preinvasive breast cancer tissue is confirmed by RT-PCR, nuclease protection assays and in-situ hybridization of ductal carcinoma in situ tissue RNA and control tissue RNA. The present invention also provides a method of screening for compounds that induce expression of the BRCA1 gene, whose product negatively regulates cell growth in both normal and malignant mammary epithlial cells.
    Type: Grant
    Filed: January 15, 1998
    Date of Patent: January 29, 2002
    Assignee: Vanderbilt University
    Inventors: Jeffrey T. Holt, Roy A. Jensen, David L. Page, Patrice S. Obermiller, Cheryl L. Robinson-Benion, Marilyn E. Thompson
  • Patent number: 6338413
    Abstract: A rack assembly for mounting telecommunications equipment is provided which will accommodate both Network Bays and UFER Bays and which provides mounting strips secured at the front and rear comers of the upright channels to better accommodate mounting digital equipment in the rack assembly.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: January 15, 2002
    Assignee: Newton Instrument Company, Inc.
    Inventors: Jonathan T. Walter, Bryan C. Caudill, Gilbert W. Reece
  • Patent number: 6327350
    Abstract: A system for collecting and processing SS7 message signaling units (MSUs) includes a network interface for copying MSUs from an SS7 signaling link or a TCP/IP signaling link. A call detail record generator communicates with the link interface to receive the copied MSUs and parse the MSUs to extract desired parameters from the MSUs. An application interface kit received commands from an application to control the flow of MSU parameters to the application in real time.
    Type: Grant
    Filed: March 28, 2000
    Date of Patent: December 4, 2001
    Assignee: Tekelec
    Inventors: Richard James Spangler, Steven Michael Freedman
  • Patent number: 6324183
    Abstract: Seamless transport of messages is provided between SS7 network elements and Internet Protocol (IP) network elements using an STP as an intermediary. Thus, messages may be routed between a first SP and a second SP via an STP using IP. Messages may be routed between an SP and an IP node via an STP using IP. Messages also may be routed between a first IP node and a second IP node via an STP using IP. Thus, the STP can be used as a vehicle for message transport among nodes of an SS7 network, among nodes of an IP network and between SS7 and IP networks. SS7 messages are bidirectionally communicated between an STP and at least one other SP of an SS7 network using IP, preferably TCP/IP. Preferably, SS7 messages are bidirectionally communicated between an STP and at least one SCP using IP.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: November 27, 2001
    Assignee: Tekelec
    Inventors: Paul Andrew Miller, David Michael Sprague, Dan Alan Brendes, Venkataramaiah Ravishankar
  • Patent number: 6313176
    Abstract: A method of therapeutically administering certain medicaments, for instance levo-deprenyl and/or levo-desmethyl deprenyl, in order to maximize the desired effects and minimize the unwanted metabolite effects on the human body, including the central nervous system, in order to maximize therapeutic effects, such as antianxiety, anticonvulsant, antidepression, antioxidant, anti-Parkinson's disease, anti-Alzheimer's disease, and hypnotic effects, and minimize unwanted side effects, such as ataxic, anxiety, and incoordination effects, of the medicament, for instance by intraoral administration and/or inhalation administration
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: November 6, 2001
    Inventors: Everett J. Ellinwood, Jr., Samir K. Gupta
  • Patent number: 6312917
    Abstract: A method of screening a candidate compound for susceptibility to metabolism by a selected enzyme. The method includes the steps of reacting the candidate compound, an indicator compound precursor and the selected enzyme, the enzyme characterized as having a side reaction associated with metabolic activity of the enzyme wherein a chemical species capable of reacting with the indicator compound precursor is produced; and detecting an indicator compound, the indicator compound produced from the indicator compound precursor by reaction with the chemical species produced from the side reaction associated with metabolic activity of the enzyme, the detection of the indicator compound indicating the susceptibility of the candidate compound to metabolism by the enzyme. A preferred example of the selected enzyme is a cytochrome P450 (CYP).
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: November 6, 2001
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Dhiren R. Thakker, Cuiping Chen
  • Patent number: 6308228
    Abstract: A system and method termed adaptive message pipelining in which two or more data paths are joined by a data movement device. The data movement device has a data path controller for each incoming and outgoing data path. Adaptive message pipelining is a dynamic policy which adjusts between a store and forward data delivery method and a cut through delivery of data based upon network and I/O bus contention in order to decrease latency and maximize system throughput.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: October 23, 2001
    Assignee: Duke University
    Inventors: Kenneth G. Yocum, Jeffrey S. Chase
  • Patent number: 6306483
    Abstract: A three-dimensionally shaped fiber network structure having both resiliency and improved softness and aesthetic properties is composed of a deformed textile fabric formed from at least one monofilament and at least one multifilament yarn and having a plurality of deformations formed as a two-dimensional array in a base region of the deformed textile fabric. The deformed textile fabric is preferably a knitted or a woven fabric. The network structure is made by forming a deformable fabric from the monofilament and the multifilament yarn and then subjecting the deformable fabric to an area-enlarging deformation process, e.g., a thermomechanical process, to produce the deformed textile fabric having the deformations formed in a base region thereof. The three-dimensional network structures may be used in a variety of articles, including cushioning materials, impact-absorbing materials, and load-bearing materials.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: October 23, 2001
    Assignee: North Carolina State University
    Inventors: William E. Bessey, Joseph S. W. Hass, Harold W. Davis
  • Patent number: 6306890
    Abstract: A compound of the formula where: n, and X are as defined in the specification, and the compound possesses selectivity for inhibition of cyclooxygenase-2.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: October 23, 2001
    Assignee: Vanderbilt University
    Inventors: Amit S. Kalgutkar, Lawrence J. Marnett